Stocks and Investing
Stocks and Investing
Fri, June 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 27, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Paul Matteis Maintained (ALNY) at Strong Buy with Increased Target to $295 on, Jun 27th, 2024
Paul Matteis of Stifel, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $215 to $295 on, Jun 27th, 2024.
Paul has made no other calls on ALNY in the last 4 months.
There are 11 other peers that have a rating on ALNY. Out of the 11 peers that are also analyzing ALNY, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $250 on, Tuesday, June 25th, 2024
- Tiago Fauth of "Wells Fargo" Maintained at Hold with Increased Target to $207 on, Tuesday, June 25th, 2024
These are the ratings of the 9 analyists that currently disagree with Paul
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $291 on, Tuesday, June 25th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $291 on, Tuesday, June 25th, 2024
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $260 on, Tuesday, June 25th, 2024
- Ritu Baral of "TD Cowen" Maintained at Strong Buy with Increased Target to $282 on, Tuesday, June 25th, 2024
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $275 on, Monday, June 24th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $283 on, Friday, June 21st, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources